Patel Sanjiv, PRES, reported a transaction classified as grant at Relay Therapeutics, Inc. involving 332465.000000 shares for an estimated $0.00. Reported holdings after the transaction were 958413.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
Stored Form 4 columns with their raw values
Badges describe filing facts only — not predictions.
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
Form 4 relationship flags and nearby filing context
President and CEO
Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 381,180 shares of restricted stock units ("RSUs") on February 10, 2025. The reporting person had n…
Includes 381,180 shares underlying RSUs.
Represents RSUs granted to the reporting person pursuant to the Issuer's 2020 Stock Option and Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock…
Includes 713,645 shares underlying RSUs.
Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 166,232 shares of RSUs on February 12, 2025. The reporting person had no discretion with respect t…
Includes 547,413 shares underlying RSUs.
These shares are held in irrevocable trusts for the benefit of the reporting person's family members. An independent trustee is trustee of the trusts. The reporting person disclaims beneficial ownersh…
0 other filings
0 recent txs